Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease.

Vasc Health Risk Manag · 2015 · PMC4278729 · PMID 25565858

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a strong trendP =0.06so close (0.05 < p ≤ 0.1)

However, there was a strong trend toward an interaction ( P =0.06) for PPG and the number of cardiovascular risk factors.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.